Log in
Enquire now

List of Alkermes (company) patents

List of Alkermes (company) patents
List of Spinal Restoration patents
List of Mitsuba Corporation patents
List of NJOY patents
List of SBIR/STTR awards granted to CytoSorbents Medical Inc.
Mobile Apps venture capital investors
Patents where
Current Assignee
Name
is
Alkermes (company)Alkermes (company)
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10183979 Fusion polypeptides comprising mucin-domain polypeptide linkers

Patent 10183979 was granted and assigned to Alkermes (company) on January, 2019 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
10183979
January 22, 2019
‌
US Patent 11351166 Methods for treating antipsychotic-induced weight gain

Patent 11351166 was granted and assigned to Alkermes (company) on June, 2022 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11351166
June 7, 2022
‌
US Patent 9359415 Ligands modified by circular permutation as agonists and antagonists

Patent 9359415 was granted and assigned to Alkermes (company) on June, 2016 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9359415
June 7, 2016
‌
US Patent 8119163 Nanoparticulate and controlled release compositions comprising cefditoren

Patent 8119163 was granted and assigned to Alkermes (company) on February, 2012 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8119163
February 21, 2012
‌
US Patent 10919902 Hetero-halo inhibitors of histone deacetylase

Patent 10919902 was granted and assigned to Alkermes (company) on February, 2021 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
10919902
February 16, 2021
‌
US Patent 10407481 Ligands modified by circular permutation as agonists and antagonists

Patent 10407481 was granted and assigned to Alkermes (company) on September, 2019 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
10407481
September 10, 2019
‌
US Patent 9428563 Ligands modified by circular permutation as agonists and antagonists

Patent 9428563 was granted and assigned to Alkermes (company) on August, 2016 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9428563
August 30, 2016
‌
US Patent 11241425 Composition for treating mental illness

Patent 11241425 was granted and assigned to Alkermes (company) on February, 2022 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11241425
February 8, 2022
‌
US Patent 11286256 Bicyclic inhibitors of histone deacetylase

Patent 11286256 was granted and assigned to Alkermes (company) on March, 2022 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11286256
March 29, 2022
‌
US Patent 10300054 Methods for treating antipsychotic-induced weight gain

Patent 10300054 was granted and assigned to Alkermes (company) on May, 2019 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
10300054
May 28, 2019
‌
US Patent 8431685 Polymer-based sustained release device

Patent 8431685 was granted and assigned to Alkermes (company) on April, 2013 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
8431685
April 30, 2013
‌
US Patent 11542276 Substituted macrocyclic compounds and related methods of treatment

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11542276
January 3, 2023
‌
US Patent 11406632 Aripiprazole formulations having increased injection speeds

Patent 11406632 was granted and assigned to Alkermes (company) on August, 2022 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11406632
August 9, 2022
‌
US Patent 9656961 Methods for treating depressive symptoms

Patent 9656961 was granted and assigned to Alkermes (company) on May, 2017 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9656961
May 23, 2017
‌
US Patent 11534480 Compositions and methods for modulating IL-10 immunostimulatory and anti-inflammatory properties

Patent 11534480 was granted and assigned to Alkermes (company) on December, 2022 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11534480
December 27, 2022
‌
US Patent 9132231 Drug delivery device

Patent 9132231 was granted and assigned to Alkermes (company) on September, 2015 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9132231
September 15, 2015
‌
US Patent 9126977 Methods for treating antipsychotic-induced weight gain

Patent 9126977 was granted and assigned to Alkermes (company) on September, 2015 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9126977
September 8, 2015
‌
US Patent 9517235 Methods for treating antipsychotic-induced weight gain

Patent 9517235 was granted and assigned to Alkermes (company) on December, 2016 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9517235
December 13, 2016
‌
US Patent 11185541 Methods for treating antipsychotic-induced weight gain

Patent 11185541 was granted and assigned to Alkermes (company) on November, 2021 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
11185541
November 30, 2021
‌
US Patent 9943514 Methods for treating antipsychotic-induced weight gain

Patent 9943514 was granted and assigned to Alkermes (company) on April, 2018 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9943514
April 17, 2018
‌
US Patent 10231963 Methods for treating depressive symptoms

Patent 10231963 was granted and assigned to Alkermes (company) on March, 2019 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
10231963
March 19, 2019
‌
US Patent 10064859 Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia

Patent 10064859 was granted and assigned to Alkermes (company) on September, 2018 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
10064859
September 4, 2018
‌
US Patent 10287250 Morphan and morphinan analogues, and methods of use

Patent 10287250 was granted and assigned to Alkermes (company) on May, 2019 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
10287250
May 14, 2019
‌
US Patent 9682936 Morphan and morphinan analogues, and methods of use

Patent 9682936 was granted and assigned to Alkermes (company) on June, 2017 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9682936
June 20, 2017
‌
US Patent 9416137 Morphan and morphinan analogues, and methods of use

Patent 9416137 was granted and assigned to Alkermes (company) on August, 2016 by the United States Patent and Trademark Office.

Alkermes (company)
Alkermes (company)
Alkermes (company)
Alkermes (company)
United States Patent and Trademark Office
United States Patent and Trademark Office
9416137
August 16, 2016
...
Results per page:
173 results
0 selected
173 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us